News

NewGenIvf prices $2.5M share offering to fund new ventures

What's the deal? NewGenIvf GroupDealroom has a profile for this one. Try Dealroom → (NASDAQ: NIVF) has priced a firm commitment underwritten offering expected to raise roughly $2.5 million in gross proceeds. The Bangkok-based company is selling 71,428,570 Class A Ordinary Shares, or pre-funded warrants in lieu, at $0.035 per share. The transaction is expected to close on or about November 20, 2026.

Who's involved? Aegis Capital Corp.Dealroom has a profile for this one. Try Dealroom → is acting as sole book-running manager. The offering is being made under an effective shelf registration statement on Form F-3, declared effective by the US Securities and Exchange Commission on November 12, 2026.

What's the endgame? NewGenIvf plans to use the net proceeds, together with existing cash, for general corporate purposes and working capital. The company, once focused on IVF and assisted reproductive services across Asia, now bills itself as a "technology-driven, diversified growth company."

The pivot: It now operates across three new arms — NewGenProperty, for real estate development in Ras Al Khaimah, United Arab Emirates; NewGenDigital, for digital asset and decentralised-finance solutions; and NewGenSup, for health and longevity products. Its IVF business is now described as "legacy."

The signal: The small raise, priced at $0.035 a share, signals a company funding an aggressive reinvention — stretching from fertility clinics into property, crypto, and longevity — on a modest cash cushion.

Read more: business.theantlersamerican.com

Image credit: Generated with Gemini

More top stories